(Q43495854)

24 November 2017

title

Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis (English)

1 reference

24 November 2017

Vaziri ND

1

1 reference

24 November 2017

Liang KH

series ordinal

2

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

24 November 2017

1 reference

24 November 2017

volume

48

1 reference

24 November 2017

issue

6

1 reference

24 November 2017

page(s)

1979-1985

1 reference

Glycosaminoglycans and chylomicron metabolism in control and nephrotic rats

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Catabolism of very low density lipoproteins in experimental nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Low-density lipoprotein metabolism in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Lipoprotein(a) in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Experimental nephrotic syndrome: removal and tissue distribution of chylomicrons and very-low-density lipoproteins of normal and nephrotic origin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Lipoprotein distribution and composition in the human nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Origin of hypercholesterolemia in chronic experimental nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Negative feedback mechanism of cholesterol synthesis in experimental nephrosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Hepatic synthesis of cholesterol in nephrotic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Studies of alteration of hepatic cholesterol metabolism in puromycin-induced nephrotic syndrome in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Characterization of active and inactive forms of rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Characteristics of rat liver microsomal 3-hydroxy-3-methylglutaryl-coenzyme A reductase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Bile acid biosynthesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Regulation of bile acid synthesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.500

7 January 2021

Identifiers

DOI

10.1038/KI.1995.500

1 reference

Dimensions Publication ID

24 November 2017

1027881383

0 references

1 reference